Biodel to Report Fourth Quarter Fiscal Year 2012 Financial Results on December
DANBURY, Conn., Dec. 14, 2012 (GLOBE NEWSWIRE) -- Biodel Inc. (Nasdaq:BIOD)
will issue its fourth quarter fiscal year 2012 financial results on December
18, 2012. Following the release of the company's financial results,Biodel's
senior management will host a conference call to discuss the results and
provide an update on the company's progress.
December 18, 2012schedule:
7:30 a.m. U.S. Eastern Time: Q4 fiscal year 2012 results will be distributed
7:45 a.m. U.S. Eastern Time: Conference call participants should dial:
+1 ( 877 ) 303 - 8028 (United States) or
+1 ( 760 ) 536 - 5167 (International)
8:00 a.m. U.S. Eastern Time: Conference call begins
Interested parties may access a live audio webcast of the conference call in
the investor section ofBiodel's website atwww.biodel.com. The audio webcast
will be archived and available for replay through the website. Interested
parties may also access an audio replay by dialing (855) 859-2056 (US) or
(404) 537-3406 (International) and entering conference ID number 73281904.
Biodel Inc.is a specialty biopharmaceutical company focused on the
development and commercialization of innovative treatments for diabetes that
may be safer, more effective and more convenient for patients. We develop our
product candidates by applying our proprietary formulation technologies to
existing drugs in order to improve their therapeutic profiles.
CONTACT: Seth D. Lewis, +1-646-378-2952
Press spacebar to pause and continue. Press esc to stop.